Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer

Molecules and Cells

Volumn 34, Issue 2, 2012, Pages 171-176

  Lee, Su Man ^a   Park, Jae Yong ^a   Kim, Dong Sun ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Methylation; Methylation specific PCR; Non small cell lung cancer; Serum; TMEFF2

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FOLLISTATIN; MEMBRANE PROTEIN; TMEFF2 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SCREENING; CONTROLLED STUDY; DNA METHYLATION; FEASIBILITY STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN METHYLATION; SMOKING;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL CULTURE TECHNIQUES; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; EPIGENOMICS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC;

EID: 84865332493     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-012-0083-5     Document Type: Article

References (33)

1. Ali, N., and Knaüper, V. (2007). Phorbol ester-induced shedding of the prostate cancer marker transmembrane protein with epidermal growth factor and two follistatin motifs 2 is mediated by the disintegrin and metalloproteinase-17. J. Biol. Chem. 282, 37378- 37388.
2. Anglim, P.P., Alonzo, T.A., and Laird-Offringa, I.A. (2008). DNA methylation-based biomarkers for early detection of non-small cell lung cancer: An update. Mol. Cancer 7, 81-94.
3. Baylin, S.B., and Ohm, J.E. (2006). Epigenetic gene silencing in cancer - an early oncogenic pathway addiction? Nat. Rev. Cancer 6, 107-116. (Pubitemid 43361543)
4. Beder, L.B., Gunduz, M., Ouchida, M., Fukushima, K., Gunduz, E., Ito, S., Sakai, A., Nagai, N., Nishizaki, K., and Shimizu, K. (2003). Genome-wide analyses on loss of heterozygosity in head and neck squamous cell carcinomas. Lab. Invest. 83, 99-105. (Pubitemid 36126054)
5. Belinsky, S.A. (2004). Gene-promoter hypermethylation as a biomarker in lung cancer. Nat. Rev. Cancer 4, 1-11.
6. Belinsky, S.A., Palmisano, W.A., Gilliland, E.D., Crooks, L.A., Divine, K.K., Winters, S.A., Grimes, M.J., Harms, H.J., Tellez, C.S., Smith, T.M., et al. (2002). Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res. 62, 2370-2377. (Pubitemid 34411720)
7. Bremnes, R.M., Sirera, R., and Camps, C. (2005). Circulating tumour- derived DNA and RNA markers in blood: A tool for early detection, diagnostics, and follow-up? Lung Cancer 49, 1-12. (Pubitemid 40798088)
8. Chung, J.H., Lee, H.J., Kim, B.H., Cho, N.Y., and Kang, G.H. (2011). DNA methylation profile during multistage progression of pulmonary adenocarcinomas. Virchows Arch. 459, 201-211.
9. Elahi, A., Zhang, L., Yeatman, T.J., Gery, S., Sebti, S., and Shibata, D. (2008). HPP1-mediated tumor suppression requires activation of STAT1 pathways. Int. J. Cancer 122, 1567-1572. (Pubitemid 351294965)
10. Field, J.K., Liloglou, T., Warrak, S., Burger, M., Becker, E., Berlin, K., Nimmrich, I., and Maier, S. (2005). Methylation discriminators in NSCLC identified by a microarray based approach. Int. J. Oncol. 27, 105-111.
11. Gery, S., Sawyers, C.L., Agus, D.B., Said, J.W., and Koeffler, H.P. (2002). TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells. Oncogene 21, 4739-4746. (Pubitemid 34879449)
12. Glynne-Jones, E., Harper, M.E., Seery, L.T., James, R., Anglin, I., Morgan, H.E., Taylor, K.M., Gee, J.M., and Nicholson, R.I. (2001). TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence. Int. J. Cancer 94, 178-184. (Pubitemid 32911410)
13. Guo, M., House, M.G., Hooker, C., Han, Y., Heath, E., Gabrielson, E., Yang, S.C., Baylin, S.B., Herman, J.G., and Brock, M.V. (2004). Promoter hypermethylation of resected bronchial margins: A field defect of changes? Clin. Cancer Res. 10, 5131-5136. (Pubitemid 39099787)
14. Heller, G., Zielinski, C.C., and Zochbauer-Muller, S. (2010). Lung cancer: From single-gene methylation to methylome profiling. Cancer Metastasis Rev. 29, 95-107.
15. Huang, Z.H., Li, L.H., Yang, F., and Wang, J.F. (2007). Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions. World J. Gastroenterol. 13, 950-954. (Pubitemid 46470311)
16. Ivanauskas, A., Hoffmann, J., Jonaitis, L.V., Markelis, R., Juozaityte, E., Kupcinskas, L., Lofton-Day, C., Rocken, C., and Malfertheiner, P. (2008). Distinct TPEF/HPP1 gene methylation patterns in gastric cancer indicate a field effect in gastric carcinogenesis. Dig. Liver Dis. 40, 920-926.
17. Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F.O., Hesch, R.D., and Knippers, R. (2001). DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 61, 1659-1665. (Pubitemid 34292602)
18. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., and Thun, M.J. (2008). Cancer statistics, 2008. CA Cancer J. Clin. 58, 71-96. (Pubitemid 351521864)
19. Jones, P.A., and Baylin, S.B. (2002). The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415-428. (Pubitemid 34587077)
20. Lee, S.M., Na, Y.K., Hong, H.S., Jang, E.J., Yoon, G.S., Park, J.Y., and Kim, D.S. (2011). Hypomethylation of the thymosin 10 gene is not associated with its overexpression in non-small cell lung cancer. Mol. Cells 32, 343-348.
21. Liang, G., Robertson, K.D., Talmadge, C., Sumegi, J., and Jones, P.A. (2000). The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells. Cancer Res. 60, 4907-4912.
22. Lin, K., Taylor, J.R., Wu, T.D., Gutierrez, J., Elliott, J.M., Vernes, J.M., Koeppen, H., Phillips, H.S., de Sauvage, F.J., and Meng, Y.G. (2011). TMEFF2 is a PDGF-AA binding protein with methyla- tion-Associated gene silencing in multiple cancer types including glioma. PLoS One 6, e18608.
23. Lofton-Day, C., Model, F., DeVos, T., Tetzner, R., Distler, J., Schuster, M., Song, X., Lesche, R., Liebenberg, V., Ebert, M., et al. (2008). DNA methylation biomarkers for blood-based colorectal cancer screening. Clin. Chem. 54, 414-423. (Pubitemid 351302625)
24. Minna, J.D., Roth, J.A., and Gazdar, A.F. (2002). Focus on lung cancer. Cancer Cell 1, 49-52. (Pubitemid 41039175)
25. Otsuka, T., Kohno, T., Mori, M., Noguchi, M., Hirohashi, S., and Yokota, J. (1996). Deletion mapping of chromosome 2 in human lung carcinoma. Genes Chromosomes Cancer 16, 113-119. (Pubitemid 26239128)
26. Russo, A.L., Thiagalingam, A., Pan, H., Califano, J., Cheng, K., Ponte, J.F., Chinnapan, D., Nemani, P., Sidransky, D., and Thiagalingam, S. (2005). Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progress of lung cancer. Clin. Cancer Res. 11, 2466-2470. (Pubitemid 40569441)
27. Sabbioni, S., Miotto, E., Veronese, A., Sattin, E., Gramantieri, L., Bolondi, L., Calin, G.A., Gafà, R., Lanza, G., Carli, G., et al. (2003). Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood. Mol. Diagn. 7, 201-207. (Pubitemid 38533789)
28. Selamat, S.A., Galler, J.S., Joshi, A.D., Fyfe, M.N., Campan, M., Siegmund, K.D., Kerr, K.M., and Laird-Offringa, I.A. (2011). DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma. PLoS One 6, e21443.
29. Shigematsu, H., and Gazdar, A.F. (2006). Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int. J. Cancer 118, 257-262. (Pubitemid 41779062)
30. Suzuki, M., Shigematsu, H., Shames, D.S., Sunaga, N., Takahashi, T., Shivapurkar, N., Lizasa, T., Frenkel, E.P., Minna, J.D, Fujisawa, T., et al. (2005). DNA methylation-Associated inactivation of TGFβ-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers. Oncogene 93, 1029-1037. (Pubitemid 41548398)
31. Takita, J., Yang, H.W., Chen, Y.Y., Hanada, R., Yamamoto, K., Teitz, T., Kidd, V., and Hayashi, Y. (2001). Allelic imbalance on chromosome 2q and alterations of the caspase 8 gene in neuroblastoma. Oncogene 20, 4424-4432. (Pubitemid 32726887)
32. Toyooka, S., Maruyama, R., Toyooka, K.O., McLerran, D., Feng, Z., Fukuyama, Y., Virmani, A.K., Zochbauer-Muller, S., Tsukuda, K., Sugio, K., et al. (2003). Smoke exposure, histologic type and geography-related differences in the methylation profiles of nonsmall cell lung cancer. Int. J. Cancer 103, 153-160. (Pubitemid 35461506)
33. Young, J., Biden, K.G., Simms, I.A., Huggard, P., Karamatic, R., Eyre, H.J., Sutherland, G.R., Herath, N., Barker, M., Anderson, G.J., et al. (2001). HPP1: A transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers. Proc. Natl. Acad. Sci. USA 98, 265-270. (Pubitemid 32095898)